相关实验视频
Updated: Jan 18, 2026

04:33
Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
1.1K
卡波普里尔诱导的咳:在儿童中是否重要? 一个回顾性队列研究
Michael Coffey1, Brian McCrossan2, Rachel Moore1
1Paediatrics, Royal Belfast Hospital for Sick Children, Belfast, UK.
Current pediatric reviews
|January 16, 2026
概括
卡普托普里尔等ACE抑制剂 (ACE-I) 引起的咳在儿童中比成年人少,影响15%的患者. 这种副作用通常被很好地容忍,很少需要改变药物.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- ангиотензин转化酶抑制剂 (ACE-I) 经常被处方用于儿科心血管疾病.
- 与成年人相比,儿童的卡普托普里尔诱导的咳报告少得多.
研究的目的:
- 调查儿童心脏病患者中ACE-I相关咳的患病率和影响.
- 为了比较卡普托普里尔诱导的咳在儿童和成人的发病率.
主要方法:
- 一项回顾性队列研究,涉及100名儿童心脏病患者,定期接受ACE-I.
- 通过电话采访和评估咳症状的问卷收集数据.
主要成果:
- 15%的儿科患者报告了与卡波普里尔相关的咳症状.
- 只有1%的患者因咳而需要改变药物.
- 在儿童中,与ACE-I相关的咳通常耐受良好.
结论:
- 与卡普托普里尔相关的咳在儿童中显得不如成年人那么严重,尽管可能比以前认为的更为普遍.
- 较低的发病率可能与儿科和成人肺部ACE表达的差异有关.
- 与ACE-I相关的咳很少需要改变儿科患者管理.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
246
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Pharmacokinetics in Pediatric Patients: Drug Distribution
254
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Drug Dosing: Infants and Children
256
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
256
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
978
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
978

